Farther Finance Advisors, LLC Neurocrine Biosciences Inc Transaction History
Farther Finance Advisors, LLC
- $2.06 Trillion
- Q2 2024
A detailed history of Farther Finance Advisors, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 442 shares of NBIX stock, worth $50,441. This represents 0.0% of its overall portfolio holdings.
Number of Shares
442
Previous 435
1.61%
Holding current value
$50,441
Previous $61.5 Million
0.7%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding NBIX
# of Institutions
641Shares Held
95.3MCall Options Held
661KPut Options Held
227K-
Black Rock Inc. New York, NY14.2MShares$1.62 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.15 Billion0.03% of portfolio
-
State Street Corp Boston, MA4.61MShares$526 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.47MShares$282 Million0.6% of portfolio
-
Jpmorgan Chase & CO New York, NY2.36MShares$270 Million0.03% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $10.9B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...